|
1.
|
Holick MF: Vitamin D deficiency. N Engl J
Med. 357:266–281. 2007. View Article : Google Scholar
|
|
2.
|
Adams JS and Hewison M: Update in vitamin
D. J Clin Endocrinol Metab. 95:471–478. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Hollis BW: Assessment of circulating
25(OH)D and 1,25(OH)2D: emergence as clinically important
diagnostic tools. Nutr Rev. 65:S87–S90. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Hollis BW: Circulating 25-hydroxyvitamin D
levels indicative of vitamin D sufficiency: implications for
establishing a new effective dietary intake recommendation for
vitamin D. J Nutr. 135:317–322. 2005.PubMed/NCBI
|
|
5.
|
Dawson-Hughes B, Heaney RP, Holick MF,
Lips P, Meunier PJ and Vieth R: Estimates of optimal vitamin D
status. Osteoporos Int. 16:713–716. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Bischoff-Ferrari HA: Optimal serum
25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp
Med Biol. 624:55–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Dusso AS, Brown AJ and Slatopolsky E:
Vitamin D. Am J Physiol Renal Physiol. 289:F8–F28. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Holick MF: Resurrection of vitamin D
deficiency and rickets. J Clin Invest. 116:2062–2072. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Dalhoff K, Dancey J, Astrup L, et al: A
phase II study of the vitamin D analogue Seocalcitol in patients
with inoperable hepatocellular carcinoma. Br J Cancer. 89:252–257.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Diaz GD, Paraskeva C, Thomas MG, Binderup
L and Hague A: Apoptosis is induced by the active metabolite of
vitamin D3 and its analogue EB1089 in colorectal adenoma and
carcinoma cells: possible implications for prevention and therapy.
Cancer Res. 60:2304–2312. 2000.PubMed/NCBI
|
|
11.
|
Vandewalle B, Wattez N and Lefebvre J:
Effects of vitamin D3 derivatives on growth, differentiation and
apoptosis in tumoral colonic HT 29 cells: possible implication of
intracellular calcium. Cancer Lett. 20:99–106. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Scaglione-Sewell BA, Bissonnette M,
Skarosi S, Abraham C and Brasitus TA: A vitamin D3 analog induces a
G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles
of cyclin E, p21Waf1, and p27Kip1. Endocrinology. 141:3931–3939.
2000.PubMed/NCBI
|
|
13.
|
Fernandez-Garcia NI, Palmer HG, Garcia M,
et al: 1alpha,25-Dihydroxyvitamin D3 regulates the expression of
Id1 and Id2 genes and the angiogenic phenotype of human colon
carcinoma cells. Oncogene. 24:6533–6544. 2005.PubMed/NCBI
|
|
14.
|
Evans SR, Shchepotin EI, Young H, Rochon
J, Uskokovic M and Shchepotin IB: 1,25-dihydroxyvitamin D3
synthetic analogs inhibit spontaneous metastases in a
1,2-dimethylhydrazine-induced colon carcinogenesis model. Int J
Oncol. 16:1249–1254. 2000.
|
|
15.
|
Lamprecht SA and Lipkin M: Cellular
mechanisms of calcium and vitamin D in the inhibition of colorectal
carcinogenesis. Ann NY Acad Sci. 952:73–87. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Ahn J, Peters U, Albanes D, et al: Serum
vitamin D concentration and prostate cancer risk: a nested
case-control study. J Natl Cancer Inst. 100:796–804. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Mucci LA and Spiegelman D: Vitamin D and
prostate cancer risk – a less sunny outlook? J Natl Cancer Inst.
100:796–804. 2008.
|
|
18.
|
Abbas S, Linseisen J, Slanger T, Kropp S,
Mutschelknauss EJ, Flesch-Janys D and Chang-Claude J: Serum
25-hydroxyvitamin D and risk of post-menopausal breast cancer –
results of a large case-control study. Carcinogenesis. 29:93–99.
2008.PubMed/NCBI
|
|
19.
|
Freedman DM, Looker AC, Chang SC and
Graubard BI: Prospective study of serum vitamin D and cancer
mortality in the United States. J Natl Cancer Inst. 99:1594–1602.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Giovannucci E, Liu Y, Rimm EB, Hollis BW,
Fuchs CS, Stampfer MJ and Willett WC: Prospective study of
predictors of vitamin D status and cancer incidence and mortality
in men. J Natl Cancer Inst. 98:451–459. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Heist RS, Zhou W, Wang Z, et al:
Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in
advanced non-small-cell lung cancer. J Clin Oncol. 26:5596–5602.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Ng K, Meyerhardt JA, Wu K, Feskanich D,
Hollis BW, Giovannucci EL and Fuchs CS: Circulating
25-hydroxyvitamin D levels and survival in patients with colorectal
cancer. J Clin Oncol. 26:2984–2991. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Pilz S, Dobnig H, Winklhofer-Roob B, et
al: Low serum levels of 25-hydroxyvitamin D predict fatal cancer in
patients referred to coronary angiography. Cancer Epidemiol
Biomarkers Prev. 17:1228–1233. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Tretli S, Hernes E, Berg JP, Hestvik UE
and Robsahm TE: Association between serum 25(OH)D and death from
prostate cancer. Br J Cancer. 100:450–454. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Zhou W, Heist RS, Liu G, et al:
Circulating 25-hydroxyvitamin D levels predict survival in
early-stage non-small-cell lung cancer patients. J Clin Oncol.
25:479–485. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Stolzenberg-Solomon RZ, Vieth R, Azad A,
Pietinen P, Taylor PR, Virtamo J and Albanes D: A prospective
nested case-control study of vitamin D status and pancreatic cancer
risk in male smokers. Cancer Res. 66:10213–10219. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Grant WB: An estimate of premature cancer
mortality in the U.S. due to inadequate doses of solar
ultraviolet-B radiation. Cancer. 94:1867–1875. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Feskanich D, Ma J, Fuchs CS, Kirkner GJ,
Hankinson SE, Hollis BW and Giovannucci EL: Plasma vitamin D
metabolites and risk of colorectal cancer in women. Cancer
Epidemiol Biomarkers Prev. 13:1502–1508. 2004.PubMed/NCBI
|
|
29.
|
Pritchard RS, Baron JA and Gerhardsson DV:
Dietary calcium, vitamin D, and the risk of colorectal cancer in
Stockholm, Sweden. Cancer Epidemiol Biomarkers Prev. 5:897–900.
1996.PubMed/NCBI
|
|
30.
|
Giovannucci E: The epidemiology of vitamin
D and cancer incidence and mortality: a review (United States).
Cancer Causes Control. 16:83–95. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Nogues X, Servitja S, Pena MJ, et al:
Vitamin D deficiency and bone mineral density in postmenopausal
women receiving aromatase inhibitors for early breast cancer.
Maturitas. 66:291–297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Neuhouser Ml, Bernstein L, Hollis BW, et
al: Serum vitamin D and breast density in breast cancer survivors.
Cancer Epidemiol Biomarkers Prev. 19:412–417. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Khan QJ, Reddy PS, Kimler BF, et al:
Effect of vitamin D supplementation on serum 25-hydroxy vitamin D
levels, joint pain, and fatigue in women starting adjuvant
letrozole treatment for breast cancer. Breast Cancer Res Treat.
119:111–118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Crew KD, Shane E, Cremers S, McMahon DJ,
Irani D and Hershman DL: High prevalence of vitamin D deficiency
despite supplementation in premenopausal women with breast cancer
undergoing adjuvant chemotherapy. J Clin Oncol. 27:2151–2156. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Rainville C, Khan Y and Tisman G: Triple
negative breast cancer patients presenting with low serum vitamin D
levels: a case series. Cases J. 2:83902009. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Waltman NL, Ott CD, Twiss JJ, Gross GJ and
Lindsey AM: Vitamin D insufficiency and musculoskeletal symptoms in
breast cancer survivors on aromatase inhibitor therapy. Cancer
Nurs. 32:143–150. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Neuhouser Ml, Sorensen B, Hollis BW, et
al: Vitamin D insufficiency in a multiethnic cohort of breast
cancer survivors. Am J Clin Nutr. 88:133–139. 2008.PubMed/NCBI
|
|
38.
|
Wang-Gillam A, Miles DA and Hutchins LF:
Evaluation of vitamin D deficiency in breast cancer patients on
bisphosphonates. Oncologist. 13:821–827. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
De Lyra EC, da Silva IA, Katayama Ml,
Brentani MM, Nonogaki S, Goes JC and Folgueira MA: 25(OH)D3 and
1,25(OH)2D3 serum concentration and breast tissue expression of
1alpha-hydroxylase, 24-hydroxylase and vitamin D receptor in women
with and without breast cancer. J Steroid Biochem Mol Biol.
100:184–192. 2006.PubMed/NCBI
|
|
40.
|
Palmieri C, MacGregor T, Girgis S and
Vigushin D: Serum 25-hydroxyvitamin D levels in early and advanced
breast cancer. J Clin Pathol. 59:1334–1336. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Charalampopoulos A, Charalabopoulos A,
Batistatou A, et al: Parathormone and 1,25(OH)2D3 but not 25(OH)D3
serum levels, in an inverse correlation, reveal an association with
advanced stages of colorectal cancer. Clin Exp Med. 10:69–72. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Fakih MG, Trump DL, Johnson CS, Tian L,
Muindi J and Sunga AY: Chemotherapy is linked to severe vitamin D
deficiency in patients with colorectal cancer. Int J Colorectal
Dis. 24:219–224. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Niv Y, Sperber AD, Figer A, Igael D, Shany
S, Fraser G and Schwartz B: In colorectal carcinoma patients, serum
vitamin D levels vary according to stage of the carcinoma. Cancer.
86:391–397. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Hofmann JN, Yu K, Horst RL, Hayes RB and
Purdue MP: Long-term variation in serum 25-hydroxyvitamin D
concentration among participants in the Prostate, Lung, Colorectal,
and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers
Prev. 19:927–931. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Laney N, Meza J, Lyden E, Erickson J,
Treude K and Goldner W: The prevalence of vitamin D deficiency is
similar between thyroid nodule and thyroid cancer patients. Int J
Endocrinol. 8057162010.(E-pub ahead of print).
|
|
46.
|
Thill M, Fischer D, Kelling K, et al:
Expression of vitamin D receptor (VDR), cyclooxygenase-2 (COX-2)
and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in benign and
malignant ovarian tissue and 25-hydroxycholecalciferol
(25(OH(2))D(3)) and prostaglandin E(2) (PGE(2)) serum level in
ovarian cancer patients. J Steroid Biochem Mol Biol. 121:387–390.
2010.
|
|
47.
|
McCombie AM, Mason RS and Damian DL:
Vitamin D deficiency in Sydney skin cancer patients. Med J Aust.
190:1022009.PubMed/NCBI
|
|
48.
|
Nurnberg B, Graber S, Gartner B, et al:
Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma
patients. Anticancer Res. 29:3669–3674. 2009.PubMed/NCBI
|
|
49.
|
Trump DL, Chadha MK, Sunga AY, et al:
Vitamin D deficiency and insufficiency among patients with prostate
cancer. BJU Int. 104:909–914. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Badros A, Goloubeva O, Terpos E, Milliron
T, Baer MR and Streeten E: Prevalence and significance of vitamin D
deficiency in multiple myeloma patients. Br J Haematol.
142:492–494. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Everett PC: The prevalence of vitamin D
deficiency and insufficiency in a hematology-oncology clinic. Clin
J Oncol Nurs. 12:33–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Reinhold U, Schmitz B, Kurbacher C, Nagel
W, Schmidt M and Malaisse WJ: Circulating 25-hydroxyvitamin D
concentration in German cancer patients. Oncol Rep. 20:1539–1543.
2008.PubMed/NCBI
|
|
53.
|
Hollender A, Bjoro T, Otto KK, Kvaloy SO,
Nome O and Holte H: Vitamin D deficiency in patients operated on
for gastric lymphoma. Scand J Gastroenterol. 41:673–681. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Lammert M, Friedman JM, Roth HJ, et al:
Vitamin D deficiency associated with number of neurofibromas in
neurofibromatosis 1. J Med Genet. 43:810–813. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
55.
|
Plant AS and Tisman G: Frequency of
combined deficiencies of vitamin D and holotranscobalamin in cancer
patients. Nutr Cancer. 56:143–148. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Reichrath J and Querings K: No evidence
for reduced 25-hydroxyvitamin D serum level in melanoma patients.
Cancer Causes Control. 15:97–98. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
Tangpricha V, Colon NA, Kaul H, et al:
Prevalence of vitamin D deficiency in patients attending an
outpatient cancer care clinic in Boston. Endocr Pract. 10:292–293.
2004.PubMed/NCBI
|
|
58.
|
Gaugris S, Heaney RP, Boonen S, Kurth H,
Bentkover JD and Sen SS: Vitamin D inadequacy among post-menopausal
women: a systematic review. QJM. 98:667–676. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Isaia G, Giorgino R, Rini GB, Bevilacqua
M, Maugeri D and Adami S: Prevalence of hypovitaminosis D in
elderly women in Italy: clinical consequences and risk factors.
Osteoporos Int. 14:577–582. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
60.
|
Plotnikoff GA and Quigley JM: Prevalence
of severe hypovitaminosis D in patients with persistent,
nonspecific musculoskeletal pain. Mayo Clin Proc. 78:1463–1470.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
61.
|
Rovner AJ and O'Brien KO: Hypovitaminosis
D among healthy children in the United States: a review of the
current evidence. Arch Pediatr Adolesc Med. 162:513–519. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
62.
|
Gordon CM, DePeter KC, Feldman HA, Grace E
and Emans SJ: Prevalence of vitamin D deficiency among healthy
adolescents. Arch Pediatr Adolesc Med. 158:531–537. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
63.
|
Looker AC, Dawson-Hughes B, Calvo MS,
Gunter EW and Sahyoun NR: Serum 25-hydroxyvitamin D status of
adolescents and adults in two seasonal subpopulations from NHANES
III. Bone. 30:771–777. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
64.
|
Tangpricha V, Pearce EN, Chen TC and
Holick MF: Vitamin D insufficiency among free-living healthy young
adults. Am J Med. 112:659–662. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
65.
|
Lips P: Vitamin D deficiency and secondary
hyperparathyroidism in the elderly: consequences for bone loss and
fractures and therapeutic implications. Endocr Rev. 22:477–501.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
66.
|
McKenna MJ: Differences in vitamin D
status between countries in young adults and the elderly. Am J Med.
93:69–77. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
67.
|
Das G, Crocombe S, McGrath M, Berry JL and
Mughal MZ: Hypovitaminosis D among healthy adolescent girls
attending an inner city school. Arch Dis Child. 91:569–572. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
68.
|
Lips P, Duong T, Oleksik A, Black D,
Cummings S, Cox D and Nickelsen T: A global study of vitamin D
status and parathyroid function in postmenopausal women with
osteoporosis: baseline data from the multiple outcomes of
raloxifene evaluation clinical trial. J Clin Endocrinol Metab.
86:1212–1221. 2001. View Article : Google Scholar
|
|
69.
|
Sullivan SS, Rosen CJ, Halteman WA, Chen
TC and Holick MF: Adolescent girls in Maine are at risk for vitamin
D insufficiency. J Am Diet Assoc. 105:971–974. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
70.
|
Yanoff LB, Parikh SJ, Spitalnik A, et al:
The prevalence of hypovitaminosis D and secondary
hyperparathyroidism in obese Black Americans. Clin Endocrinol.
64:523–529. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
71.
|
Bell NH, Epstein S, Greene A, Shary J,
Oexmann MJ and Shaw S: Evidence for alteration of the vitamin
D-endocrine system in obese subjects. J Clin Invest. 76:370–373.
1985. View Article : Google Scholar : PubMed/NCBI
|
|
72.
|
De Boer IH, Ioannou GN, Kestenbaum B,
Brunzell JD and Weiss NS: 25-Hydroxyvitamin D levels and
albuminuria in the Third National Health and Nutrition Examination
Survey (NHANES III). Am J Kidney Dis. 50:69–77. 2007.
|
|
73.
|
Chatfield SM, Brand C, Ebeling PR and
Russell DM: Vitamin D deficiency in general medical inpatients in
summer and winter. Intern Med J. 37:377–382. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
74.
|
Olmez D, Bober E, Buyukgebiz A and Cimrin
D: The frequency of vitamin D insufficiency in healthy female
adolescents. Acta Paediatr. 95:1266–1269. 2006. View Article : Google Scholar : PubMed/NCBI
|
